京新药业(002020.SZ)：累计回购5.49%公司股份

Core Viewpoint - Jingxin Pharmaceutical (002020.SZ) has completed its share repurchase program, acquiring a total of 47.27 million shares, which represents 5.49% of the company's total share capital [1] Summary by Categories Share Repurchase Details - The company repurchased shares through a dedicated securities account via centralized bidding [1] - The highest purchase price for the shares was 14.41 CNY per share, while the lowest was 11.86 CNY per share [1] - The total amount spent on the repurchase was 608.72 million CNY, excluding transaction fees [1] Compliance and Strategy - The share repurchase complies with relevant laws and regulations [1] - The repurchase aligns with the company's established share repurchase plan [1]